Table 1.
Analyzed Parameter | MO | KO | DO |
---|---|---|---|
Gender | Male | Female | Female |
SAT diagnosis date | October 2016 | June 2017 | August 2017 |
TSH (n: 0.27–4.2 mIU/L) | 0.01 | 1.07 | 0.01 |
FT3 (n: 2.6–4.4 pg/mL) | 5.64 | 3.27 | 7.78 |
FT4 (n: 0.93–1.7 ng/dL) | 2.43 | 1.17 | 3.02 |
aTPO (n: < 34 IU/mL) | 7.25 | 13.06 | 8.36 |
aTg (n: < 115 IU/mL) | 10 | 114.5 | 73.02 |
TRAb (n: < 1.75 IU/mL) | 0.56 | 5.38 | 0.48 |
ESR (n: < 12 mm/h) | 93 | 44 | 84 |
CRP (n: < 1 mg/dL) | 8.11 | 1.1 | 3.91 |
Neck pain | yes | yes | yes |
Fever | yes | yes | yes |
Sonographic pattern | Several hypoechoic areas | Several hypoechoic areas | Several hypoechoic areas |
Preceding infection | no | yes | no |
Antibiotic treatment before SAT diagnosis |
no | yes (azitromicin) | no |
Recurrence | no | Yes—3 episodes | no |
Living together | no | yes | yes |
The laboratory results out of the normal range are presented in bold. Abbreviations: aTg, thyroglobulin antibodies; aTPO, thyroid peroxidase antibodies; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; FT3, free triiodothyronine; FT4, free thyroxine; n, normal values; TRAb, thyrotropin receptor antibodies, TSH, thyrotropin. MO: a 34-year-old male, DO: MO’s 31-year-old sister, KO: DO’s twin-sister.